13F Filings History of Aquilo Capital Management, LLC
- Latest 13F filing
- Q1 2025 - 15 May 2025
- Latest reported 13F value
- $0
- Largest 13F holdings
-
BPMC ARWR PTGX KYMR DTIL ARVN RGNX ACET BCYC IMTX RPTX ZYME
- Form 13F summary
-
- Aquilo Capital Management, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Aquilo Capital Management, LLC reported 12 equity holdings with a total reported market value of $37,083,888 for Q1 2025. Top reported holdings included BPMC, ARWR, PTGX, KYMR, and DTIL.
- Manager signature
- Marc Schneidman - Managing Member
- Manager location
- San Francisco, CA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Aquilo Capital Management, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2025
Latest value
$37,083,888
Quarter delta
+$37,083,888
Accepted
15 May 2025, 16:09
Rows shown
1-25 of 30
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | $0 | $0 | $0 | 13F-HR | 12 Nov 2025, 16:42 | |
| Q2 2025 | 0 | $0 | $0 | -$37,083,888 | -$37,083,888 | 13F-HR | 06 Aug 2025, 16:40 | |
| Q1 2025 | 12 | $37,083,888 | +$2,382,674 | -$11,138,031 | -$8,755,357 | BPMC, ARWR, PTGX, KYMR, DTIL | 13F-HR | 15 May 2025, 16:09 |
| Q4 2024 | 13 | $58,391,158 | +$5,571,418 | -$15,630,576 | -$10,059,158 | ARWR, BPMC, KYMR, ARVN, BCYC | 13F-HR | 14 Feb 2025, 16:45 |
| Q3 2024 | 13 | $88,843,058 | +$3,387,115 | -$13,685,474 | -$10,298,359 | ARWR, BPMC, KYMR, RGNX, ARVN | 13F-HR | 14 Nov 2024, 16:48 |
| Q2 2024 | 13 | $103,725,464 | +$10,238,532 | -$18,024,921 | -$7,786,389 | ARWR, BPMC, ARVN, RGNX, KYMR | 13F-HR | 14 Aug 2024, 16:17 |
| Q1 2024 | 10 | $133,418,069 | +$11,622,354 | -$44,773,452 | -$33,151,098 | ARWR, RGNX, BPMC, ARVN, KYMR | 13F-HR | 15 May 2024, 16:22 |
| Q4 2023 | 9 | $142,595,237 | +$8,951,006 | -$28,453,556 | -$19,502,550 | ARWR, BPMC, KYMR, ARVN, SLN | 13F-HR | 14 Feb 2024, 16:29 |
| Q3 2023 | 12 | $110,354,745 | +$5,450,126 | -$27,171,046 | -$21,720,920 | ARWR, BPMC, RGNX, SLN, KYMR | 13F-HR | 14 Nov 2023, 16:38 |
| Q2 2023 | 12 | $152,361,620 | +$6,280,416 | -$47,298,968 | -$41,018,552 | ARWR, BPMC, MRUS, RGNX, ARVN | 13F-HR | 14 Aug 2023, 16:26 |
| Q1 2023 | 11 | $170,677,812 | +$2,276,769 | -$24,613,808 | -$22,337,039 | BPMC, ARWR, MRUS, KYMR, ARVN | 13F-HR | 15 May 2023, 16:36 |
| Q4 2022 | 12 | $224,715,570 | +$11,648,991 | -$19,242,717 | -$7,593,726 | ARWR, BPMC, ARVN, MRUS, RGNX | 13F-HR | 14 Feb 2023, 16:27 |
| Q3 2022 | 14 | $237,765,000 | +$23,350,616 | -$35,642,896 | -$12,292,280 | ARWR, BPMC, MRUS, ARVN, RGNX | 13F-HR | 14 Nov 2022, 16:22 |
| Q2 2022 | 12 | $237,333,000 | +$19,138,236 | -$9,522,513 | +$9,615,723 | ARWR, BPMC, MRUS, ARVN, RGNX | 13F-HR | 15 Aug 2022, 16:53 |
| Q1 2022 | 12 | $342,581,000 | +$60,767,752 | -$13,977,000 | +$46,790,752 | BPMC, ARWR, ARVN, SPRO, RGNX | 13F-HR | 16 May 2022, 16:27 |
| Q4 2021 | 13 | $406,738,000 | +$94,171,090 | -$62,867,651 | +$31,303,439 | SPRO, BPMC, ARWR, ARVN, RGNX | 13F-HR | 14 Feb 2022, 16:15 |
| Q3 2021 | 13 | $424,877,000 | +$95,708,390 | -$43,241,000 | +$52,467,390 | SPRO, BPMC, DRNA, QURE, RGNX | 13F-HR | 15 Nov 2021, 16:14 |
| Q2 2021 | 15 | $384,863,000 | +$40,564,893 | -$13,506,828 | +$27,058,065 | DRNA, SPRO, BPMC, ARWR, QURE | 13F-HR | 16 Aug 2021, 16:11 |
| Q1 2021 | 15 | $366,663,000 | +$84,230,972 | -$27,659,161 | +$56,571,811 | SPRO, DRNA, BPMC, NGM, HARP | 13F-HR | 17 May 2021, 16:09 |
| Q4 2020 | 15 | $335,045,000 | +$31,838,265 | -$43,645,452 | -$11,807,187 | SPRO, BPMC, NGM, DRNA, ARWR | 13F-HR | 16 Feb 2021, 16:25 |
| Q3 2020 | 15 | $244,247,000 | +$45,668,986 | -$25,641,424 | +$20,027,562 | SPRO, BPMC, DRNA, QURE, ARWR | 13F-HR | 16 Nov 2020, 16:39 |
| Q2 2020 | 13 | $272,017,000 | +$67,982,377 | -$26,329,000 | +$41,653,377 | DRNA, ANAB, QURE, SPRO, BPMC | 13F-HR | 14 Aug 2020, 16:34 |
| Q1 2020 | 13 | $179,141,000 | +$77,744,832 | -$10,096,783 | +$67,648,049 | QURE, DRNA, ANAB, XENE, SPRO | 13F-HR | 15 May 2020, 16:38 |
| Q4 2019 | 11 | $147,349,000 | +$49,120,465 | -$8,736,000 | +$40,384,465 | QURE, PRQR, PIRS, XENE, GLPG | 13F-HR | 14 Feb 2020, 16:26 |
| Q3 2019 | 9 | $88,130,000 | +$8,523,533 | -$38,784,090 | -$30,260,557 | MRUS, QURE, SPRO, PIRS, BCYC | 13F-HR | 14 Nov 2019, 16:33 |